Delineation of Human B Cell Differentiation: Immunological and Molecular Characterization of Human B Cell Differentiation Factor (BSF-2)

  • Tadamitsu Kishimoto
  • Toshio Hirano
  • Hitoshi Kikutani
  • Atsushi Muraguchi
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 213)


B cells, which are responsible for the secretion of antibodies, originate from pluripotent hematopoietic stem cells and differentiation stages, such as pre-B cells, mature B cells, activated B cells and antibody secreting cells. The commitment of each B cell clone to a specific antigen occurs at the pre-B cell level and mature B cells express IgM molecules as antigen receptors on their surface. Binding of an antigen complementary to the receptors of a certain B cell clone initiates a complex series of the activation process resulting into antibody secreting cells. This process of clonal expansion and differentiation requires the collaboration of helper T cells. Recently, the T cell-dependent activation process of B cells into antibody secreting cells has been extensively studied and the involvement of B cell specific growth and differentiation factors in this process has been demonstrated (1,2). The results are schematically summarized in Fig. 1.


Culture Supernatant Phosphatidyl Inositol Partial Amino Acid Sequence Antibody Secreting Cell Cell Differentiation Factor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Miller and W. E. Paul. Regulation of B-cell growth and differentiation by soluble factors. Annual Rev. Immunol. 1:307 (1983).CrossRefGoogle Scholar
  2. 2.
    T. Kishimoto. Factors affecting B cell growth and differentiation. Annu. Rev. Immunol. 3:135 (1985).CrossRefGoogle Scholar
  3. 3.
    E. M. Rabin, J. Ohara, and W. E. Paul. B-cell stimulatory factor 1 activates resting B cells. Proc. Natl. Acad. Sci. USA. 82:2935, (1985).ADSCrossRefGoogle Scholar
  4. 4.
    T. Kishimoto, K. Yoshizaki, M. Kimoto, M. Okada, T. Kuritani, H. Kikutani, K. Shimizu, T. Nakagawa, N. Nakagawa, Y. Miki, H. Kishi, K. Fukunaga, T. Yoshikubo, and T. Taga. B cell growth and differentiation factors and mechanism of B cell activation. Immunol. Rev. 78:97, (1984).CrossRefGoogle Scholar
  5. 5.
    T. Hirano, T. Taga, N. Nakano, K. Yasukawa, S. Kashiwamura, K. Shimizu, K. Nakajima, K. H. Pyun, and T. Kishimoto. Purification homogeneity and characterization of human B celL differentiation factor (BCDF or BSFp-2). Proc. Natl. Acad. Sci. USA. 82:5490(1985).ADSCrossRefGoogle Scholar
  6. 6.
    S. Maruyama, T. Naito, H. Kakita, S. Kishimoto, Y. Yamamura, and T. Kishimoto. Preparation of a monoclonal antibody against human monocyte. J. Clin. Immunol. 3:57, (1983).CrossRefGoogle Scholar
  7. 7.
    H. Kikutani, R. Kimura, H. Nakamura, R. Sato, A. Muraguchi, N. Kawamura, R. R. Hardy, and T. Kishimoto. Expression and function of an early activation marker restricted to human B cells. L Immunol, (in press).Google Scholar
  8. 8.
    D. R. Parks, R. R. Hardy, and L. A. Herzenberg. Dual Immunofluorescence-News frontiers in cell analysis and sorting. Immunol. Today. 4:145 (1983).CrossRefGoogle Scholar
  9. 9.
    S. Hashida, M. Imagawa, S. Inoue, K. H. Ruan, and E. Ishikawa. More useful maleimide compounds for the conjugation of Fab’ to horseradish peroxidase through thiol groups in the hinge. J. Applied Biochemistry. 6:56 (1984).Google Scholar
  10. 10.
    W. E. Marzluff, and R. C. Huang. Transcription of RNA in isolated nuclie, In Transcription and translation ed. by Hames, B. D. and Higgins, S. J. pp 89–120, IRL Press, Oxford (1984).Google Scholar
  11. 11.
    H. Hidaka, M. Inagaki, S. Kawamoto, and Y. Sasaki. Isoquinolinesulfonamede, novel and potent inhibitors of cyclic nucleotide dependent protein kinase and protein kinase C. Biochemistry. 23:5036 (1984).CrossRefGoogle Scholar
  12. 12.
    D. A. Cantrell, and K. A. Smith. Transient expression of interleukin 2 receptors Consequences for T cell growth. J. Exp. Med. 158:1895, (1983).CrossRefGoogle Scholar
  13. 13.
    M. Howard, J. J. Farrar, M. Hilfiker, B. Johnson, K. Takatsu, T. Hamaoka, and W. E. Paul. Identification of a T cell-derived B cell growth factor distinct from interleukin 2. J. Exp. Med. 155:914 (1982).CrossRefGoogle Scholar
  14. 14.
    M. Okada, N. Sakaguchi, N. Yoshimura, H. Hara, K. Shimizu, N. Yoshida, K. Yoshizaki, S. Kishimoto, Y. Yamamura, and T. Kishimoto. B cell growth factor (BCGF) and B cell differentiation factor from human T hybridomas: Two distinct kinds of BCGFs and their synergism in B cell proliferation. J. Exp. Med. 157:583 (1983).CrossRefGoogle Scholar
  15. 15.
    J. Imboden, and J. Stobo. Transmembrane signalling by the T cell antigen receptor. Perturbation of the T3-antigen receptor complex generates inositol phosphates and releases calcium ions from intracellular stores. J. Exp. Med. 161:446 (1985).CrossRefGoogle Scholar
  16. 16.
    A. Truneh, F. Albert, P. Golstein, and A. Schmit-Verhulst. Early steps of lymphocyte activation bypassed by synergy between calcium ionophores and phorbol ester. Nature 313:318 (1985).ADSCrossRefGoogle Scholar
  17. 17.
    K. M. Congreshall, and J. C. Cambier. B cell activation VIII. Membrane immunoglobulins transduce signals via activation of phosphatidylinositol hydrolysis. J. Immunol. 133:3382(1984).Google Scholar
  18. 18.
    M. G. S. JU. Sutton, L. Mercier, E. R. Giuliani, and J. T. Lie. Atrial Myxomas A review of clinical experience in 40 patients. Mavo Clin. Proc. 55:371 (1980).Google Scholar
  19. 19.
    A. Schimpl, and E. Wecker. Replacement of T cell function by a T cell product. Nature 237:15 (1972).Google Scholar
  20. 20.
    S. L. Swain, G. Dennert, J. F. Warner, and R. W. Dutton. Culture supernatants of a stimulated T-cell line have helper activity that acts synergistically with interleukin 2 in the response of B cell to antigen. Proc. Natl. Acad. Sci. 78:2517 (1981).ADSCrossRefGoogle Scholar
  21. 21.
    H. J. Leibson, P. Marrack, and J.W. Kappler. B cell helper factors. I. Requirement for both interleukin 2 and another 40,000 mol. wt. factor. J. Exp. Med. 154:1681 (1981).CrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1987

Authors and Affiliations

  • Tadamitsu Kishimoto
    • 1
  • Toshio Hirano
    • 1
  • Hitoshi Kikutani
    • 1
  • Atsushi Muraguchi
    • 1
  1. 1.the Institute for Molecular and Cellular BiologyOsaka UniversityOsakaJapan

Personalised recommendations